Archive for the ‘Parkinson's Disease’ Category
Monday, August 11th, 2008
A cross-national project on Parkinson disease assessment calls the attention for the role of behavioral factors in Parkinson disease. The study points to new trends in Parkinson's disease assessment, which eventually would expand to social functioning ascertainment. The present study is part of the ELEP project, a longitudinal ...
Posted in Parkinson's Disease | No Comments »
Sunday, August 3rd, 2008
The Michael J. Fox Foundation for Parkinson's Research has announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative. This annual MJFF program provides intellectual and financial resources to help push potential PD drug targets forward toward clinical trials and ultimately the nearly five ...
Posted in Parkinson's Disease | No Comments »
Wednesday, July 30th, 2008
The Michael J. Fox Foundation for Parkinson's Research has announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative. This annual MJFF program provides intellectual and financial resources to help push potential PD drug targets forward toward clinical trials and ultimately the nearly five ...
Posted in Parkinson's Disease | No Comments »
Sunday, June 15th, 2008
The European Medicines Agency (EMEA) has recommended the immediate implementation of changes to the product information for Neupro (rotigotine), from Schwarz Pharma Ltd, stating that it must be stored in a refrigerator (at a temperature of between 2oC and 8oC). The new storage conditions are intended to reduce the possible ...
Posted in Parkinson's Disease | No Comments »
Thursday, June 5th, 2008
A Binghamton University researcher will receive $1.33 million from the National Institutes of Health to support Parkinson's research that will focus not only on the treatment of the disease but also on the side effects of treatment."Parkinson's disease patients have trouble with movement," said Christopher Bishop, assistant professor of psychology. ...
Posted in Parkinson's Disease | No Comments »
Friday, May 30th, 2008
GlaxoSmithKline (GSK) have announced the launch of a new treatment for Parkinson's disease (PD) in the UK. ReQuip XL® (ropinirole prolonged-release tablets) is the UK's first and only once-daily non-ergot oral dopamine agonist available for the treatment of PD1, providing continuous delivery of ropinirole from a single daily dose2. ...
Posted in Parkinson's Disease | No Comments »
Thursday, April 10th, 2008
Scientists have reprogrammed adult rat skin cells to become embryonic-like stem cells and alleviate Parkinson's disease in rats, according to a study published Monday in the Proceedings of the National Academy of Sciences, the Boston Globe reports. According to the Globe, the study might have both political and medical significance ...
Posted in Parkinson's Disease | No Comments »
Wednesday, April 9th, 2008
Scientists in the US made new brain cells by inserting reprogrammed adult skin cells into fetal mouse brains and then used them to reduce symptoms of Parkinson's disease in rats. While this is a long way from demonstrating such a method might be effective in humans, it brings that ...
Posted in Parkinson's Disease | No Comments »
Tuesday, April 1st, 2008
Regular use of some pesticides can "more than double the risk of developing Parkinson's disease", The Daily Telegraph reports. Research has found that "people who reported using insect sprays or weed killers at home or as part of their job, faced a more than 60% greater risk of developing the ...
Posted in Parkinson's Disease | No Comments »
Saturday, March 29th, 2008
The injection of uterine stem cells trigger growth of new brain cells in mice with Parkinson's disease, Yale School of Medicine researchers report in an abstract presented at the 2008 Society for Gynecologic Investigation (SGI) Annual Scientific Meeting held March 26-29 in San Diego, California."Previously, we were able to coax ...
Posted in Parkinson's Disease | No Comments »
Saturday, March 29th, 2008
The injection of uterine stem cells trigger growth of new brain cells in mice with Parkinson's disease, Yale School of Medicine researchers report in an abstract presented at the 2008 Society for Gynecologic Investigation (SGI) Annual Scientific Meeting held March 26-29 in San Diego, California."Previously, we were able to coax ...
Posted in Parkinson's Disease | No Comments »
Friday, March 28th, 2008
In a step closer to developing a treatment for Parkinson's in humans using therapeutic cloning, scientists in the US and Japan have for the first time used cells from a mouse to treat Parkinson's in the same mouse.The study is published in the advanced online issue of the journal Nature ...
Posted in Parkinson's Disease | No Comments »
Friday, March 28th, 2008
Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice. The study's results are published in the March 23 online edition of the journal Nature Medicine.For the first time, ...
Posted in Parkinson's Disease | No Comments »
Friday, March 28th, 2008
Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice. The study's results are published in the March 23 online edition of the journal Nature Medicine.For the first time, ...
Posted in Parkinson's Disease | No Comments »
Friday, March 28th, 2008
Power3 Medical Products, Inc. (OTCBB: PWRM, http://https://www.power3medical.com), a leading proteomics company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases, commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer's disease and Parkinson's disease. The ...
Posted in Parkinson's Disease | No Comments »
